(L-R) Gary Walker, Paddy Graham (BGF) and Mark Walker
High-precision component manufacturer, Walker Precision Engineering, has secured a £4m investment from BGF to expand its operations in the UK and mainland Europe.
From premises in Glasgow, Basildon and Poland, the family-owned business manufactures and assembles complex parts for the aerospace, defence and industrial sectors.
The funding will allow the business to invest in specialist machinery, further increasing its high accuracy machining capacity. The business has experienced an increase in demand from existing and new customers, particularly in the burgeoning space market.
In addition to further investment at its Glasgow HQ, the BGF funding will see Walker move its Basildon operations to a new purpose-built facility and double the capacity of its manufacturing facility in Poland.
Mark Walker, managing director at Walker Precision Engineering, said: “Walker has grown steadily over the years through our deep commitment to investing in technical expertise and innovation.
“We first met BGF back in 2012 and since then have been getting to know the team and how it operates. Now is the right time to bring on board a minority investor. BGF’s funding will help us pursue new opportunities in the market faster than we would otherwise have been able to do, without losing control of the business.”
Paddy Graham, BGF investor, added: “Walker is one of the leaders in its field, having built a strong heritage and long-standing customer relationships. Having known the business for a number of years, we’ve seen the team successfully scale up its operations and customer base and break into the space market.
“There are significant opportunities for Walker to expand its capacity further in both existing and in new markets. We’re delighted to be helping the team capitalise on this.”
The investment in Walker brings the total BGF funding in Scottish businesses to more than £200m. Its portfolio of growing companies includes Campion Homes, Bar Soba, Keenan Recycling and M Squared Lasers, which has been more than doubling its revenues every two years since BGF’s investment in 2012.
BGF provides patient capital to businesses with revenues typically between £5m and £100m in exchange for a minority, non-controlling stake. BGF invests exclusively in small and mid-sized firms headquartered in the UK and Ireland, and is in the top ten most active investors globally.